Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingwei Zhitong pellet-based quadruple therapy vs bismuth quadruple therapy for Helicobacter pylori eradication
ChiCTR2200066296Phase 4Recruiting
- Sponsor
- Civil Aviation General Hospital
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Qingwei Zhitong pellets in Helicobacter pylori infection (2 arms), sponsored by Civil Aviation General Hospital. Primary endpoint: Helicobacter pylori eradication by 13C urea breath test. Started Oct 2022; status: recruiting.
02
Drugs
Qingwei Zhitong pellets
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200066296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066296.